Genome-scale Quantitative Tumour Proteomics for Cancer Biomarkers Discovery
Metodi Metodiev, Lecturer/Director of Proteomics Unit, University of Essex, speaking at European Biomarkers Summit 2011.
Mode of Action Analysis and Biomarker Discovery Using Mass Spectrometry-Based Phosphoproteomics Technologies
Andreas Jenne, CEO, Kinaxo, speaking at European Biomarkers Summit 2011.
Development of a Blood Based Molecular Test to Aid in the Diagnosis of Schizophrenia
Emanuel Schwarz, Post Doctoral Researcher, University of Cambridge, speaking at European Biomarkers Summit 2011.
Metabolomics and Proteomics Data Integration: From Single Model Organisms to Ecosystems
Wolfram Weckwerth, University of Vienna, speaking at Advances in Metabolic Profiling 2010.
Metabolomics Platform for Toxicology Research in Zebrafish
Elwin Verheij, TNO, speaking at European Biomarkers Summit 2010.
Targeted Metabolomics Applications of Mass Spectrometry in Biomedical and Environmental Analyses
Ed Dudley, Lecturer, University of Swansea, speaking at Mass Spectrometry Europe 2010.
Metabolic Profiling Analyses in Staphylococci Reveal an Adaptive Metabolic Homeostasis in Response to Environmental Stresses
Richard Hugh Dunstan, Head of School, University of Newcastle, speaking at Advances in Metabolic Profiling 2010.
Metabolomics of Sebum Within-Classes Distribution of Sebaceous Lipid Metabolites in Healthy Skin and Acne
Emanuela Camera, Principle Researcher, Dermatological Institute of San Gallicano, speaking at European Biomarkers Summit 2010.
Biomarkers of Metabolic Syndrome in Clinical Trials
This will discuss the latest developments in biomarkers for metabolic syndrome. The topics will include: 1) Pre-analytical and analytical concerns regarding gut and incretin hormones, 2) dysfunctional HDL biomarkers in metabolic syndrome, and 3) kidney injury markers and their usefulness in diabetic nephropathy.